PRTA (Prothena) Earnings per share growth rate in current year
Prothena Corporation (PRTA) minimizes risks through partnerships with tech giants in the treatment of neurodegenerative pathologies. The YoY earnings per share growth rate confirms this stability. Flawless cold chain control and diversification of component supplies guarantee the success of clinical trials, while 99.90 serves as the final mark for this metric's level.
Financial and market metric breakdowns for prothena.com (PRTA)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Prothena Corporation|PRTA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Prothena|PRTA - Company Debts|Debts to Book Value Prothena Biosciences|PRTA - Company Long-Term Debt|Company Short-Term Loans and Borrowings Prothena|Critical Liquidity Ratio prothena.com
- earnings and market ratios statistics:
PRTA - Company Net Income|Expected Net Profit Prothena Corporation|PRTA - Price to Earnings Ratio|Future Price to Earnings Multiple Prothena Corp|PRTA - PEG Multiple|EV/EBITDA Multiple Prothena Biosciences|PRTA - Operating profit before deduction of amortization|Earnings per share for the last four quarters Prothena|PRTA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months prothena.com|PRTA - Earnings per share growth in current year|Expected net earnings per share growth next year Prothena Corporation
- sales volume and revenue information:
Basic company analysis:PRTA Prothena Corporation PLC
This indicator measures the dynamics of earnings per share, identifying growth driven by operational efficiency or a reduction in the number of shares outstanding. By analyzing the annual change in EPS, an investor can distinguish genuine business development from an artificial inflation of returns, which for Prothena Corporation (PRTA) is supported by the stability of the biomedical sector and the absence of geopolitical restrictions.
Main competitors
Biogen Inc - Earnings per share increase in current year|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|Earnings per share growth rate in current year Regencell Corp RGC|Earnings per share growth in current year Axsome Therapeutics (AXSM)|acadia-pharm.com - Earnings per share growth this year|Earnings growth in current year XENE (Xenon)|Earnings growth in current year Viking Therapeutics Inc VKTX|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (Catalyst Corp)|DNLI: Earnings growth in current year|Net earnings per share growth this year harmonybiosciences.com|Earnings per share growth in current year Biohaven|Earnings per share growth rate in current year Amylyx Pharmaceuticals Inc AMLX|Earnings per share growth in current year Trevi Pharma (TRVI)|PRAX (Praxis Corp) - Earnings per share increase in current year|Earnings per share growth in current year Anavex Life Sciences AVXL|CBLL (ceribell.com) - Earnings per share trend in current year|ALEC - Earnings per share growth in current year|Earnings per share growth rate in current year Annexon Biosciences|omeros.com (OMER) - Earnings per share growth in current year|Neurogene Therapeutics - Earnings per share increase in current year|ACIU (AC Immune) - Earnings growth in current year|Earnings growth in current year voyagertherapeutics.com|Net earnings per share growth this year NMRA (Neumora Therapeutics, Inc.)|Net earnings per one share growth for the current year SCLX|Earnings growth in current year TVGN (Tevogen Bio Holdings, Inc.)|Expected net earnings per share growth this year Alpha Cognition Inc (ACOG)|CGTX - Earnings per share growth in current year|Earnings per share growth rate in current year inhibikase.com|Cassava Sciences (SAVA) - Earnings per share growth in current year|Earnings per share growth this year ASRT|Earnings per share growth in current year Coya Therapeutics Inc|VistaGen Therapeutics Inc - Earnings per share trend in current year|Earnings per share growth in current year Ovid Therapeutics Inc. (OVID)|ABOS (acumenpharm.com) - Earnings per share increase in current year|CervoMed - Net earnings per share growth this year|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd.)|Clene Nanomedicine - Earnings growth in current year|PEPG - Earnings growth in current year|Jupiter Neurosciences (JUNS) - Earnings per share growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio) - Earnings growth in current year|Earnings per share growth rate in current year Grace Tx GRCE|Net earnings per share growth this year AIFF (Firefly Neuroscience Inc)|Earnings growth in current year anewmeds.com (KLTO)|Earnings per share growth in current year NeuroSense Therapeutics Ltd. NRSN|Earnings per share increase in current year RVPH|MTVA - Earnings per share growth in current year|Earnings per share growth rate in current year NeurAxis Inc.|heliusmedical.com (HSDT) - Earnings per share growth in current year|Earnings per share trend in current year PASG (Passage Bio)|Earnings per share growth in current year Neuphoria Therapeutics, Inc.|NERV: Earnings per share increase in current year|Earnings per share growth in current year Athira Pharma (ATHA)|ADXN - Earnings per share growth rate in current year|Alzamend Neuro - Net earnings per share growth this year|Net earnings per one share growth for the current year CYCN (Cyclerion Therapeutics Inc.)|Protagenic - Earnings growth in current year|Earnings per share increase in current year KTTA (Pasithea Therapeutics)|CRGT: Earnings growth in current year|Earnings per share growth rate in current year Avenue Therapeutics Inc. (ATXI)|Earnings per share growth in current year Brainstorm Cell Therapeutics, Inc.|Earnings per share growth this year CARA (Cara Therapeutics Inc)|Earnings growth in current year CHRO|Earnings growth in current year eliemtx.com (ELYM)|Intra-Cellular Therapies, Inc. - Net earnings per share growth this year|Earnings per share increase in current year LBPH|Marinus - Earnings growth in current year|NKGen Biotech Corp (NKGN) - Net earnings per share growth this year|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth rate in current year sagerx.com (SAGE)|Earnings per share growth in current year Synaptogenix|TRVN: Earnings per share increase in current year|Earnings per share growth in current year Vigil Neuroscience (VIGL)|WENA: Earnings per share trend in current year|Earnings per share growth in current year Cerevel Therapeutics CERE
